FDA Drug Application (009218) for COUMADIN by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number009218
Product Number005
FormTABLET;ORAL
Dosage10MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCOUMADIN
Active IngredientWARFARIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient WARFARIN SODIUM5


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB